Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,103 GBX | -1.57% | -1.96% | +14.36% |
11:29am | AstraZeneca Says Potential Lung Cancer Treatment Improved Overall Survival Compared With Chemotherapy | MT |
10:17am | ASTRAZENECA : JP Morgan reiterates its Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.36% | 243B | |
+38.51% | 727B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+7.59% | 205B | |
-5.97% | 203B | |
+6.19% | 164B | |
+0.31% | 164B | |
-1.02% | 122B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : UBS remains a Sell rating